Benign breast disease

Obstetrics and Gynecology Clinics of North America

Volumn 29, Issue 1, 2002, Pages 1-20

  Marchant, Douglas J ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANALGESIC AGENT; BROMOCRIPTINE; DANAZOL; RETINOL; VITAMIN D;

BREAST ADENOMA; BREAST CANCER; BREAST CYST; BREAST DISEASE; BREAST FIBROADENOMA; BREAST HAMARTOMA; BREAST HYPERPLASIA; BREAST INJURY; CONFERENCE PAPER; CYSTOSARCOMA PHYLLOIDES; DISEASE COURSE; FIBROCYSTIC BREAST DISEASE; GRANULAR CELL TUMOR; HUMAN; LIPOMA; MASTALGIA; MEDICAL LITERATURE; PATIENT REFERRAL; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SIDE EFFECT; SYMPTOMATOLOGY;

EID: 0036190827     PISSN: 08898545     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8545(03)00048-2     Document Type: Review

References (63)

1. Benign breast disorders in non-western populations: Part I - Benign breast disorders in Chinese women
2. Benign breast disease; the cost of the service and the cost to the patient
3. Benign breast disease
4. Inflammatory, infectious, and metabolic disorders of the breast
5. Inflammatory, infectious, and metabolic disorders of the breast
6. Reproducibility and validity of pathologic classification of benign breast disease and implications for clinical application
7. Diabetic mastopathy: Complication of type I diabetes mellitus: A report of two cases and review of the literature
8. Pseudoangiomatous stromal hyperplasia: Mammographic, sonographic and clinical patterns
9. Cytologic study of fluid from benign breast cysts
10. Clinical trials in the premenstrual syndrome
11. The endocrine basis of benign breast disorder
12. Estrogen replacement therapy in women with a history of proliferative disease
13. Influence of exogenous estrogens, proliferative breast disease and other variables on breast cancer risk
14. Risk factors for breast cancer in women with proliferative breast disease
15. Continuation of postmenopausal replacement therapy: Comparison of cyclic versus continuous combined schedules
16. Breast masses: Mammographic and sonographic evaluation
17. Morphological evaluation of cell turnover in relation to the menstrual cycle in the “resting” human breast
18. Cat scratch disease presenting as a breast mass
19. Proliferative and secretory activity in human breast during natural and artificial menstrual cycles
20. Galactocele: Three distinctive appearances
21. The treatment of benign breast disease with Danazol
22. Aberrations of normal development and involution (Andi): A new perspective on pathogenesis and nomenclature of benign breast disorders
23. Lymphocytic mastitis and fibrosis of the breast in long standing insulin dependent diabetics: A histopathologic study on diabetic mastopathy and report of ten cases
24. Goodbye to fibrocystic disease
25. The effect of vitamin E on mammary dysplasia: A double blind study
26. Sounding Board: Fibrocystic “disease” of the breast - A non-disease?
27. A case controlled study of caffeine and methylxanthenes in benign breast disease
28. Cystosarcoma phylloides
29. Nonendocrine theories of the etiology of benign breast disease
30. Treatment of benign breast disease with Bromocriptine
31. Relationship of histologic features to behavior of cystosarcoma phylloides
32. Benign breast disorders in nonwestern populations: Part 3-benign breast disorders in northern Nigeria
33. Atypical hyperplastic lesions of the female breast: A long-term follow-up study
34. Relation between component parts of fibrocystic disease complex and breast cancer
35. Diabetic mastopathy: A report of two cases diagnosed by aspiration cytology
36. Perspective on vitamin E as therapy: Commentary
37. Juvenile (cellular) adenofibromas: A clinico pathologic study
38. Diabetic fibrous disease: A clinical entity that mimics cancer
39. Pseudoangiomatous stromal hyperplasia (PASH): A mammary stromal tumor with myofibroblastic differentiation
40. The importance of mastalgia in operable breast cancer
41. Mastalgia and total body water
42. Case report: Granular cell tumor of the breast
43. Proliferative breast “disease”: A unresolved diagnostic dilemma
44. The early diagnosis of breast cancer
45. Sensory neuropathy from pyridoxine abuse: A new megavitamin syndrome
46. Benign circumscribed breast masses: Mammographic and sonographic appearance
47. Fluid level in a galactocele seen on lateral projection mammogram with a horizontal beam
48. Benign breast disease, Part I: Hormonal investigation
49. Benign lesions
50. Benign lesions
51. Benign lesions
52. Benign lesions
53. Benign lesions
54. Benign lesions
55. Benign lesions
56. Granular cell myoblastoma of the breast
57. Vitamin E relieves most cystic breast disease; may alter lipids, hormones
58. Fibrocystic breast disease: Pathophysiology, pathomorphology, clinical picture, and management
59. The surgeon and the pathologist; a plea for reciprocity as illustrated by the consideration of the classification and treatment of benign tumors of the breast